DDHA 8601 Week 3 Technology Evaluation Example

One Worklist for Four Manufacturers' Device Transmissions: A Technology Evaluation That Sets Each Vendor Claim Beside the Nursing Task It Would Change, and Marks Two Claims Unverified

Student Name

Walden University

DDHA 8601: Technology and Innovation in Healthcare

Instructor Name

Month Day, Year

One Worklist for Four Manufacturers' Device Transmissions: A Technology Evaluation That Sets Each Vendor Claim Beside the Nursing Task It Would Change, and Marks Two Claims Unverified

The Decision

Linden Ford Community Hospital, a composite 260-bed hospital, runs a cardiac device clinic that follows about 1,850 patients with pacemakers, implantable defibrillators, cardiac resynchronization devices and implantable loop recorders. The clinic already uses remote monitoring: each device sends transmissions to its manufacturer's website, and the clinic's three device nurses review them. The decision this evaluation answers is whether the hospital should license a vendor-neutral platform that would pull transmissions from all four manufacturers into one worklist inside the hospital's network, at a quoted cost the next section of the course will examine. The evaluation judges the platform against the specific tasks the device nurses do now, not against rival products.

The Nursing Tasks in Question

The device nurses perform six tasks related to remote monitoring. They log into four separate manufacturer websites each morning. They review each new transmission and decide whether it needs action. They document each reviewed transmission in the hospital's record, mostly by typing a summary and attaching a report as a scanned file. They call patients whose devices have not transmitted on schedule. They schedule in-clinic device checks when a transmission shows a problem or a check is due. And they prepare documentation for billing remote interrogations. The nurse manager estimates that these tasks take about two thirds of the nurses' working time, with the rest spent on in-clinic device checks and patient calls about symptoms.

The Claims and Their Evidence

Two claims are supported by strong evidence, and both are about remote monitoring in general rather than about this platform. Varma et al. (2010) found that automatic remote monitoring of defibrillators reduced in-hospital device evaluations by about 45% without harming safety. Crossley et al. (2011) found that remote notification cut the median time from a clinical event to a clinical decision from 22 days to under 5. These findings are more than a decade old, and they describe what Linden Ford already does. The platform cannot claim them as its own benefit, because the clinic already has remote monitoring.

Two claims are marked unverified. The vendor says review time per transmission falls by half, citing its own white paper, which reports an internal analysis at customer sites without describing how time was measured. It says the platform filters out nonactionable transmissions safely, but I found no published evaluation of how often its filter hides a transmission a nurse would have acted on. Both claims bear directly on the decision, and neither has independent support.

Table 1

Platform Claims, Sources and Status

Each claim is restated in the evaluator's words; sources and dates show how current the support is.

Comparing the Capability Against the Tasks

Set against the six tasks, the platform's value is narrower than its marketing suggests. It clearly removes the four daily logins, which the nurses estimate take 20 to 30 minutes each morning. It may remove most of the typing involved in documentation, if the interface sends discrete data into the record, but that depends on an interface build the hospital has not scoped. It does not change the review itself unless the time-saving claim is true, and that claim is unverified. It may help with missed transmissions, since a single worklist shows overdue devices across manufacturers in one place. It does not change scheduling or billing preparation, which happen in the hospital's own systems.

The filtering claim deserves particular caution. Slotwiner et al. (2015), in an expert consensus statement on remote monitoring of cardiac devices, recommend remote monitoring as standard care and emphasize that clinics need clear processes and accountability for reviewing and acting on alerts. A filter that hides transmissions shifts part of that accountability to software whose performance has not been independently tested. If the clinic uses the filter, it should first run it in parallel with full nurse review and compare what each would have acted on.

Two Questions Outside the Claims

Two further questions sit outside the claims table but bear on the decision. The platform receives transmissions through each manufacturer's data feed, so a delay or outage at any manufacturer reaches the worklist, and the vendor could not say how often feeds had lagged at its other sites. And patient data would leave the manufacturers' systems for a third party's servers, which the hospital's privacy and security office will need to review before any pilot. Neither question argues against trying the platform, but both belong in the contract rather than in a later conversation.

Recommendation

The evaluation recommends a six-month pilot rather than a purchase, under three conditions. First, the contract must include the interface that sends transmission data into the record as discrete fields, priced and scheduled, because documentation is where the clearest time savings lie. Second, the vendor must agree to a measured pilot in which nurse time per transmission is recorded before and after, using a method the hospital defines, since the central time-saving claim rests only on the vendor's own analysis. Third, the filtering feature must run in parallel with full review for the first three months, with every disagreement examined. If the vendor declines the second condition, the hospital should not proceed, because it would be paying for a claim it cannot test.

References

Crossley, G. H., Boyle, A., Vitense, H., Chang, Y., & Mead, R. H. (2011). The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: The value of wireless remote monitoring with automatic clinician alerts. Journal of the American College of Cardiology, 57(10), 1181-1189. https://doi.org/10.1016/j.jacc.2010.12.012

Slotwiner, D., Varma, N., Akar, J. G., Annas, G., Beardsall, M., Fogel, R. I., Galizio, N. O., Glotzer, T. V., Leahy, R. A., Love, C. J., McLean, R. C., Mittal, S., Morichelli, L., Patton, K. K., Raitt, M. H., Ricci, R. P., Rickard, J., Schoenfeld, M. H., Serwer, G. A., . . . Yu, C.-M. (2015). HRS expert consensus statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. Heart Rhythm, 12(7), e69-e100. https://doi.org/10.1016/j.hrthm.2015.05.008

Varma, N., Epstein, A. E., Irimpen, A., Schweikert, R., & Love, C. (2010). Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: The Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation, 122(4), 325-332. https://doi.org/10.1161/CIRCULATIONAHA.110.937409